Exicure Inc (XCUR)

Exicure Inc (XCUR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.3M; returns 1 day -7.1%, 1 week -6.3%, 1 year -77.8%.

Exicure, Inc. is a clinical-stage biotechnology company that underwent a significant strategic pivot in January 2025. Historically focused on developing nucleic acid therapies based on its proprietary Spherical Nucleic Acid (SNA) technology, the company has now shifted its primary focus to therapeutics for hematologic diseases.

Groups XCUR belongs to

• Biotechnology
• Clinical Stage Biotech
• Clinical Stage
• Hematology
• GPCR Targeting
• Strategic Pivot
• Hematologic Malignancies
• Oncology
• Healthcare

XCUR financial model: income statement, cash flow and balance sheet